Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Study suggests that colds may temporarily increase stroke risk in kids

A new study suggests that colds and other minor infections may temporarily increase stroke risk in children. The study is published in the August 20, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

21 Aug 2014

5 ways to fight Lewy body dementia

Today, the Lewy Body Dementia Association (LBDA) steps up its awareness and fundraising effort "Lewy Who?" to put the brakes on Lewy body dementia (LBD). With symptoms that resemble both Alzheimer's and Parkinson's disease, LBD is the most misdiagnosed form of dementia.

20 Aug 2014

Study helps explain why sleep becomes more fragmented with age

As people grow older, they often have difficulty falling asleep and staying asleep, and tend to awaken too early in the morning.

20 Aug 2014

Regulation of stem cells in zebrafish embryos results in surprising insights into Alzheimer's Disease

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.

20 Aug 2014

Researchers uncover role of epigenetic changes in Alzheimer's disease

A team led by researchers at the University of Exeter Medical School and King's College London has uncovered some of the strongest evidence yet that epigenetic changes in the brain play a role in Alzheimer's disease.

19 Aug 2014

Study shows bryostatin plays key role in slowing or reversing Alzheimer's disease

Neurotrope, Inc. (OTCQB: NTRP) today announced that results from a new study, entitled, "PKCe Deficits in Alzheimer's Disease Brains and Skin Fibroblasts," published in the recent edition of the peer-reviewed Journal of Alzheimer's Disease and co-authored by Tapan K. Khan, Ph.D.; Abhik Sen, Ph.D.; Jarin Hongpaisan, Ph.D.; Chol S. Lim, Ph.D.; Thomas J. Nelson, Ph.D., and; Dr. Daniel L. Alkon, each of the Blanchette Rockefeller Neurosciences Institute (BRNI), provide further indication of the role that protein kinase C epsilon (PKCe) may play in the potential treatment of Alzheimer's disease (AD).

19 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

Researchers reveal how early changes in DNA methylation involved in Alzheimer's disease

A new study led by researchers at Brigham and Women's Hospital (BWH) and Rush University Medical Center, reveals how early changes in brain DNA methylation are involved in Alzheimer's disease.

18 Aug 2014

Yizhijiannao granule may exert therapeutic effect by inhibiting neural cell apoptosis

Previous studies have shown that Yizhijiannao granule can enhance cognitive performance in Alzheimer's disease patients and Alzheimer's disease-model mice.

14 Aug 2014

Reducing brain levels of tau protein effectively blocks development of childhood epilepsy

Researchers at the Gladstone Institutes have shown that reducing brain levels of the protein tau effectively blocks the development of disease in a mouse model of Dravet syndrome, a severe intractable form of childhood epilepsy.

14 Aug 2014

Lead levels in foods prepared in aluminum pots from Cameroon exceed US guidelines for lead intake

Lead levels in foods prepared in aluminum pots from Cameroon exceed U.S. guidelines for lead consumption according to a new study published this month.

13 Aug 2014

Decline in daily functioning linked with Alzheimer's disease is related to alterations in brain activity

Decline in daily functioning associated with Alzheimer's disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer's Disease.

13 Aug 2014

Researchers determine safety and effectiveness of neurostimulation to treat chronic pain

Chronic pain, which persists despite the fact that an injury has healed, can last for many months or years and may affect up to 15 percent of the adult population at any point in time.

13 Aug 2014

In vivo dopaminergic imaging strongly correlates with brain pathology

Striatal dopamine transporter binding, assessed using single-photon emission computed tomography, is strongly correlated with substantia nigra cell counts assessed at postmortem, say the authors of a study.

11 Aug 2014

Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.

11 Aug 2014

Scientists identify mechanism by which inherited neurological disease causes muscle weakness in men

Researchers at University of California, San Diego School of Medicine have identified the mechanism by which a rare, inherited neurodegenerative disease causes often crippling muscle weakness in men, in addition to reduced fertility.

11 Aug 2014

People who develop depression, MCI after age 65 are more vulnerable for accelerated brain aging

People who develop depression and mild cognitive impairment (MCI) after age 65 are more likely to have biological and brain imaging markers that reflect a greater vulnerability for accelerated brain aging, according to a study conducted by researchers at the University of Pittsburgh School of Medicine. The findings were published online in Molecular Psychiatry.

8 Aug 2014

Infectious prion protein is marker for variant Creutzfeldt-Jakob disease

The misfolded and infectious prion protein that is a marker for variant Creutzfeldt-Jakob disease - linked to the consumption of infected cattle meat - has been detected in the urine of patients with the disease by researchers at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

8 Aug 2014

People diagnosed with MCI are more likely to increase risk of developing dementia

In a long-term, large-scale population-based study of individuals aged 55 years or older in the general population researchers found that those diagnosed with mild cognitive impairment (MCI) had a four-fold increased risk of developing dementia or Alzheimer's disease (AD) compared to cognitively healthy individuals.

7 Aug 2014

Low levels of vitamin D may double dementia, Alzheimer's risks

In the largest study of its kind, researchers suggests that in older people, not getting enough vitamin D may double the risk of developing dementia and Alzheimer's disease. The study is published in the August 6, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Aug 2014

Alzheimer's Disease News and Research

Further Reading

Study suggests that colds may temporarily increase stroke risk in kids

5 ways to fight Lewy body dementia

Study helps explain why sleep becomes more fragmented with age

Regulation of stem cells in zebrafish embryos results in surprising insights into Alzheimer's Disease

Researchers uncover role of epigenetic changes in Alzheimer's disease

Study shows bryostatin plays key role in slowing or reversing Alzheimer's disease

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Researchers reveal how early changes in DNA methylation involved in Alzheimer's disease

Yizhijiannao granule may exert therapeutic effect by inhibiting neural cell apoptosis

Reducing brain levels of tau protein effectively blocks development of childhood epilepsy

Lead levels in foods prepared in aluminum pots from Cameroon exceed US guidelines for lead intake

Decline in daily functioning linked with Alzheimer's disease is related to alterations in brain activity

Researchers determine safety and effectiveness of neurostimulation to treat chronic pain

In vivo dopaminergic imaging strongly correlates with brain pathology

Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Scientists identify mechanism by which inherited neurological disease causes muscle weakness in men

People who develop depression, MCI after age 65 are more vulnerable for accelerated brain aging

Infectious prion protein is marker for variant Creutzfeldt-Jakob disease

People diagnosed with MCI are more likely to increase risk of developing dementia

Low levels of vitamin D may double dementia, Alzheimer's risks

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News